Copper
CAS 7440-50-8
Copper (CAS 7440-50-8) is a pharmaceutical compound with 0 bioactivity targets and 1,271 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Copper is linked to DTXSID2023985 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| COPPER | 2837 | SU | MTHSPL |
| Copper | 2837 | SU | MTHSPL |
| copper | 2837 | IN | RXNORM |
Side Effects
SIDER side-effect terms mapped to the drug or same-CAS compound identity.
| Side Effect | Drug Name | MedDRA Type | Concept ID |
|---|---|---|---|
| Abortion infected | copper | LLT | C0000817 |
| Abortion infected | copper | PT | C0000817 |
| Allergic skin reaction | copper | LLT | C0863090 |
| Anaemia | copper | LLT | C0002871 |
| Anaemia | copper | PT | C0002871 |
| Back pain | copper | LLT | C0004604 |
| Back pain | copper | PT | C0004604 |
| Cramp muscle | copper | LLT | C0026821 |
| Dermatitis atopic | copper | PT | C0011615 |
| Dysmenorrhoea | copper | LLT | C0013390 |
| Dysmenorrhoea | copper | PT | C0013390 |
| Dyspareunia | copper | LLT | C1384606 |
| Dyspareunia | copper | PT | C1384606 |
| Ectopic pregnancy | copper | LLT | C0032987 |
| Ectopic pregnancy | copper | PT | C0032987 |
| Haemoglobin | copper | PT | C0518015 |
| Haemorrhage | copper | LLT | C0019080 |
| Haemorrhage | copper | PT | C0019080 |
| Leukorrhea | copper | LLT | C0023533 |
| Metrorrhagia | copper | PT | C0025874 |
| Muscle spasms | copper | PT | C0037763 |
| Neoplasm malignant | copper | LLT | C0006826 |
| Neoplasm malignant | copper | PT | C0006826 |
| Pain | copper | LLT | C0030193 |
| Pain | copper | PT | C0030193 |
| Pelvic infection | copper | LLT | C0030790 |
| Pelvic infection | copper | PT | C0030790 |
| Pregnancy | copper | LLT | C0032961 |
| Pregnancy | copper | PT | C0032961 |
| Spotting menstrual | copper | LLT | C0312414 |
| Urticaria | copper | LLT | C0042109 |
| Urticaria | copper | PT | C0042109 |
| Vaginal discharge | copper | PT | C0227791 |
| Vaginal infection | copper | PT | C0404521 |
| Vaginal inflammation | copper | LLT | C0042267 |
| Vaginal inflammation | copper | PT | C0042267 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Copper used for in pharmaceutical contexts?
Copper (CAS 7440-50-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Copper?
Copper has 1,271 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal distension, Abdominal pain, Abdominal pain upper, Abnormal faeces, Anaemia. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Copper also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Bronze Powder (CI 77400) with EU status "permitted".
What clinical phase is Copper in?
No phase 1-4 clinical development badge is rendered for Copper because the matched compound identifier rows do not contain a max-phase value.